CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shijiazhuang Yiling Pharmaceutical Co Ltd Company Snapshot
Shijiazhuang Yiling Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shijiazhuang Yiling Pharmaceutical Co Ltd with three other companies in this sector in China: Zhangzhou Pientzehuang Pharmaceutical Ltd (2018 sales of 4.77 billion Chinese Renmimbi [US$694.76 million] of which 49% was Pharmaceutical Business), 3sbio Inc (4.58 billion Chinese Renmimbi [US$668.19 million] of which 100% was Pharmaceutical), and Shenzhen Salubris Pharmaceuticals Co Ltd (4.65 billion Chinese Renmimbi [US$678.10 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. Shijiazhuang Yiling Pharmaceutical Co Ltd reported sales of 4.81 billion Chinese Renmimbi (US$701.81 million) for the year ending December of 2018. This represents an increase of 18.0% versus 2017, when the company's sales were 4.08 billion Chinese Renmimbi. Sales at Shijiazhuang Yiling Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 93%). Sales of Antiflu saw an increase that was more than double the company's growth rate: sales were up 85.0% in 2018, from 651.37 million Chinese Renmimbi to 1.20 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shijiazhuang Yiling Pharmaceutical Co Ltd
  Stock Performance Chart for Shijiazhuang Yiling Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 12.90
(Figures in Chinese Renmimbi)
1 Week 4.4%   13 Weeks 13.2%  
4 Weeks 15.9%   52 Weeks 17.1%  
 
Shijiazhuang Yiling Pharmaceutical Co Ltd Key Data:
  Ticker: 002603 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 4,814,530,227
(Year Ending Jan 2019).
Employees: 5,218
  Currency: Chinese Renmimbi Market Cap: 15,561,354,921
  Fiscal Yr Ends: December Shares Outstanding: 1,206,306,583
  Share Type: Class A Closely Held Shares: 761,579,235
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.